Skip to main content
Top
Published in: BMC Nephrology 1/2012

Open Access 01-12-2012 | Research article

“Looking back to my family”: Indigenous Australian patients’ experience of hemodialysis

Authors: Kate Anderson, Joan Cunningham, Jeannie Devitt, Cilla Preece, Alan Cass

Published in: BMC Nephrology | Issue 1/2012

Login to get access

Abstract

Background

In common with Indigenous populations elsewhere, Indigenous Australians have higher incidence of end-stage kidney disease (ESKD), but lower transplantation rates than their non-Indigenous counterparts. Understanding how the demands of dialysis impact on, and are impacted by, the lives of Indigenous patients may provide important insight into treatment pathways and decision-making.

Methods

We conducted semi-structured interviews in 2005–06 with 146 Indigenous and 95 non-Indigenous patients from nine hospital renal wards and 17 associated dialysis centres, which together treat the majority of Indigenous Australian ESKD patients.

Results

Factors influencing treatment experience included: the impacts of late diagnosis; family separations associated with relocating for treatment; the physical and psychosocial demands of hemodialysis; and ineffective communication between health care providers and patients. Although not unique to them, Indigenous patients were more likely to experience the combined effect of all factors.

Conclusions

Social/situational circumstances profoundly affect Indigenous Australian dialysis patients’ ability to fully engage with treatment. This may ultimately affect their likelihood of receiving optimal treatment, including transplantation. Areas for improvement include: earlier diagnosis; improved linkages between specialist renal services and primary care in regional settings; more effective communication and patient education; and more systematic, transparent approaches to patient “compliance” in transplant and home dialysis guidelines.
Literature
1.
go back to reference McDonald S, Excell L, Jose M: End-stage kidney disease among Indigenous peoples of Australia and New Zealand. ANZDATA Registry Report 2010. Edited by: McDonald S, Excell L, Livingston B. 2011, Adelaide, SA: Australia and New Zealand Dialysis and Transplant Registry, 12.1-12.12. McDonald S, Excell L, Jose M: End-stage kidney disease among Indigenous peoples of Australia and New Zealand. ANZDATA Registry Report 2010. Edited by: McDonald S, Excell L, Livingston B. 2011, Adelaide, SA: Australia and New Zealand Dialysis and Transplant Registry, 12.1-12.12.
2.
go back to reference US Renal Data System: USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2010, Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases US Renal Data System: USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2010, Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
3.
go back to reference Yeates K, Tonelli M: Chronic kidney disease among aboriginal people living in Canada. Clin Nephrol. 2010, 74 (Suppl 1): S57-S60.PubMed Yeates K, Tonelli M: Chronic kidney disease among aboriginal people living in Canada. Clin Nephrol. 2010, 74 (Suppl 1): S57-S60.PubMed
4.
go back to reference Yeates KE, Cass A, Sequist TD, McDonald SP, Jardine MJ, Trpeski L, Ayanian JZ: Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. Kidney Int. 2009, 76: 659-664. 10.1038/ki.2009.236.CrossRefPubMed Yeates KE, Cass A, Sequist TD, McDonald SP, Jardine MJ, Trpeski L, Ayanian JZ: Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. Kidney Int. 2009, 76: 659-664. 10.1038/ki.2009.236.CrossRefPubMed
5.
go back to reference Thorne SE: Negotiating Healthcare: The Social Context of Chronic Illness. 1993, Newbury Park, CA: SageCrossRef Thorne SE: Negotiating Healthcare: The Social Context of Chronic Illness. 1993, Newbury Park, CA: SageCrossRef
6.
go back to reference Australian Bureau of Statistics and Australian Institute of Health and Welfare: The Health and Welfare of Australia’s Aboriginal and Torres Strait Islander Peoples. 2008, Canberra, ACT: Australian Bureau of Statistics and Australian Institute of Health and Welfare Australian Bureau of Statistics and Australian Institute of Health and Welfare: The Health and Welfare of Australia’s Aboriginal and Torres Strait Islander Peoples. 2008, Canberra, ACT: Australian Bureau of Statistics and Australian Institute of Health and Welfare
7.
go back to reference Preston-Thomas A, Cass A, O’Rourke P: Trends in the incidence of treated end-stage kidney disease among Indigenous Australians and access to treatment. Aust NZ J Publ Health. 2007, 31: 419-421. 10.1111/j.1753-6405.2007.00111.x.CrossRef Preston-Thomas A, Cass A, O’Rourke P: Trends in the incidence of treated end-stage kidney disease among Indigenous Australians and access to treatment. Aust NZ J Publ Health. 2007, 31: 419-421. 10.1111/j.1753-6405.2007.00111.x.CrossRef
8.
go back to reference Australian Institute of Health and Welfare: Chronic Kidney Disease in Australia. 2005, Canberra, ACT: Australian Institute of Health and Welfare Australian Institute of Health and Welfare: Chronic Kidney Disease in Australia. 2005, Canberra, ACT: Australian Institute of Health and Welfare
9.
go back to reference Bennett E, Manderson L, Kelly B, Hardie I: Cultural factors in dialysis and renal transplantation among Aborigines and Torres Strait Islanders in north Queensland. Aust J Public Health. 1995, 19: 610-615.CrossRefPubMed Bennett E, Manderson L, Kelly B, Hardie I: Cultural factors in dialysis and renal transplantation among Aborigines and Torres Strait Islanders in north Queensland. Aust J Public Health. 1995, 19: 610-615.CrossRefPubMed
10.
go back to reference Devitt J, McMasters A: “They don't last too long”: Aboriginal patient experience of end-stage renal disease in Central Australia. Nephrology. 1998, 4 (Suppl): S111-S117.CrossRef Devitt J, McMasters A: “They don't last too long”: Aboriginal patient experience of end-stage renal disease in Central Australia. Nephrology. 1998, 4 (Suppl): S111-S117.CrossRef
11.
go back to reference Cass A, Cunningham J, Anderson K, Snelling P, Colman S, Devitt J, Preece C, Eris J: Decision-making about suitability for kidney transplantation: Results of a national survey of Australian nephrologists. Nephrology. 2007, 12: 299-304. 10.1111/j.1440-1797.2007.00784.x.CrossRefPubMed Cass A, Cunningham J, Anderson K, Snelling P, Colman S, Devitt J, Preece C, Eris J: Decision-making about suitability for kidney transplantation: Results of a national survey of Australian nephrologists. Nephrology. 2007, 12: 299-304. 10.1111/j.1440-1797.2007.00784.x.CrossRefPubMed
12.
go back to reference Anderson K, Devitt J, Cunningham J, Preece C, Jardine M, Cass A: “If you can't comply with dialysis, how do you expect me to trust you with transplantation?” Australian nephrologists’ views on Indigenous Australians’ ‘non-compliance’ and their suitability for kidney transplantation. Int J Equity Health. 2012, in press Anderson K, Devitt J, Cunningham J, Preece C, Jardine M, Cass A: “If you can't comply with dialysis, how do you expect me to trust you with transplantation?” Australian nephrologists’ views on Indigenous Australians’ ‘non-compliance’ and their suitability for kidney transplantation. Int J Equity Health. 2012, in press
13.
go back to reference Devitt J, Cass A, Cunningham J, Preece C, Anderson K, Snelling P: Study Protocol – Improving Access to Kidney Transplants (IMPAKT): a detailed account of a qualitative study investigating barriers to transplant for Australian Indigenous people with end-stage kidney disease. BMC Health Serv Res. 2008, 8: 31-10.1186/1472-6963-8-31.CrossRefPubMedPubMedCentral Devitt J, Cass A, Cunningham J, Preece C, Anderson K, Snelling P: Study Protocol – Improving Access to Kidney Transplants (IMPAKT): a detailed account of a qualitative study investigating barriers to transplant for Australian Indigenous people with end-stage kidney disease. BMC Health Serv Res. 2008, 8: 31-10.1186/1472-6963-8-31.CrossRefPubMedPubMedCentral
14.
go back to reference Warnecke RB, Johnson TP, Chavez N, Sudman S, O’Rourke DP, Lacey L, Horm J: Improving question wording in surveys of culturally diverse populations. Ann Epidemiol. 1997, 7: 334-342. 10.1016/S1047-2797(97)00030-6.CrossRefPubMed Warnecke RB, Johnson TP, Chavez N, Sudman S, O’Rourke DP, Lacey L, Horm J: Improving question wording in surveys of culturally diverse populations. Ann Epidemiol. 1997, 7: 334-342. 10.1016/S1047-2797(97)00030-6.CrossRefPubMed
15.
go back to reference Silverman D: Interpreting Qualitative Data. Methods for Analysing Talk, Text and Interaction. 1993, London, England: Sage Silverman D: Interpreting Qualitative Data. Methods for Analysing Talk, Text and Interaction. 1993, London, England: Sage
16.
go back to reference Ulin P, Robinson E, Tolley E: Qualitative Methods in Public Health. A Field Guide for Applied Research. 2005, San Francisco, CA: Jossey Bass Ulin P, Robinson E, Tolley E: Qualitative Methods in Public Health. A Field Guide for Applied Research. 2005, San Francisco, CA: Jossey Bass
17.
go back to reference Wilson R, Krefting L, Sutcliffe P, Van Bussel L: Native Canadians relocating for renal dialysis. Psychosocial and cultural issues. Can Fam Physician. 1994, 40: 1934-1941.PubMedPubMedCentral Wilson R, Krefting L, Sutcliffe P, Van Bussel L: Native Canadians relocating for renal dialysis. Psychosocial and cultural issues. Can Fam Physician. 1994, 40: 1934-1941.PubMedPubMedCentral
18.
go back to reference Kolewaski C, Yeates K: Chronic kidney disease among Indigenous populations: considerations for effective and ethical research. J Nephrol. 2009, 22: 571-579.PubMed Kolewaski C, Yeates K: Chronic kidney disease among Indigenous populations: considerations for effective and ethical research. J Nephrol. 2009, 22: 571-579.PubMed
19.
go back to reference Anderson K, Devitt J, Cunningham J, Preece C, Cass A: "All they said was my kidneys were dead": Indigenous Australian patients' understanding of their chronic kidney disease. Med J Aust. 2008, 189: 499-503.PubMed Anderson K, Devitt J, Cunningham J, Preece C, Cass A: "All they said was my kidneys were dead": Indigenous Australian patients' understanding of their chronic kidney disease. Med J Aust. 2008, 189: 499-503.PubMed
20.
go back to reference Cass A, Lowell A, Christie M, Snelling PL, Flack M, Marrnganyin B, Brown I: Sharing the true stories: improving communication between Aboriginal patients and healthcare workers. Med J Aust. 2002, 176: 466-470.PubMed Cass A, Lowell A, Christie M, Snelling PL, Flack M, Marrnganyin B, Brown I: Sharing the true stories: improving communication between Aboriginal patients and healthcare workers. Med J Aust. 2002, 176: 466-470.PubMed
21.
go back to reference Humphery K, Weeramanthri T, Fitz J: Forgetting Compliance: Aboriginal Health and Medical Culture. 2001, Darwin, NT: Northern Territory University Press Humphery K, Weeramanthri T, Fitz J: Forgetting Compliance: Aboriginal Health and Medical Culture. 2001, Darwin, NT: Northern Territory University Press
Metadata
Title
“Looking back to my family”: Indigenous Australian patients’ experience of hemodialysis
Authors
Kate Anderson
Joan Cunningham
Jeannie Devitt
Cilla Preece
Alan Cass
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2012
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-13-114

Other articles of this Issue 1/2012

BMC Nephrology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine